The cost-effectiveness of hypertension management in low-income and middle-income countries: a review
Hypertension in low-income and middle-income countries (LMICs) is largely undiagnosed and uncontrolled, representing an untapped opportunity for public health improvement. Implementation of hypertension control strategies in low-resource settings depends in large part on cost considerations. However...
Main Authors: | Kunihiro Matsushita, Andrew E Moran, Rachel Nugent, Laura K Cobb, Deliana Kostova, Garrison Spencer, Muhammad Jami Husain, Biplab Kumar Datta |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-09-01
|
Series: | BMJ Global Health |
Online Access: | https://gh.bmj.com/content/5/9/e002213.full |
Similar Items
-
Hypertension in women: the role of adolescent childbearing
by: Biplab K. Datta, et al.
Published: (2021-07-01) -
Disease and demography: a systems-dynamic cohort-component population model to assess the implications of disease-specific mortality targets
by: Deliana Kostova, et al.
Published: (2021-06-01) -
Noncommunicable disease-attributable medical expenditures, household financial stress and impoverishment in Bangladesh
by: Biplab Kumar Datta, et al.
Published: (2018-12-01) -
Ranking 93 health interventions for low- and middle-income countries by cost-effectiveness.
by: Susan Horton, et al.
Published: (2017-01-01) -
Consumption displacement in households with noncommunicable diseases in Bangladesh.
by: Biplab Kumar Datta, et al.
Published: (2018-01-01)